Added to YB: 2015-12-04
Pitch date: 2015-12-04
ALKS:US [bullish]
Alkermes plc
-31.71%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.
Market Cap
$6.2B
Pitch Price
$54.11
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
40.68
EV/Sales
4.63
Sector
Biotechnology
Category
N/A
Show full summary:
ALKERMES PLC COM ALKS:US
A summary for this pitch has not been created yet.
Read full article (0 min)